Predictors of Perceived Functional Status in Early Systemic Sclerosis: A Prospective Longitudinal Study of an Early Disease Cohort.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
05 2023
Historique:
revised: 27 09 2021
received: 10 12 2020
accepted: 21 10 2021
pmc-release: 01 05 2024
medline: 26 4 2023
pubmed: 6 11 2021
entrez: 5 11 2021
Statut: ppublish

Résumé

The modified Health Assessment Questionnaire (M-HAQ) is a well-established patient-reported outcome measure in systemic sclerosis (SSc) studies that reflects how a patient functions in several categories of activities of daily living. This study analyzed clinical, demographic, and socioeconomic factors that predict M-HAQ scores over time. This study included 388 patients with baseline M-HAQ scores from the Genetics versus Environment in Scleroderma Outcome Study (GENISOS) early disease cohort with a mean disease duration of 2.5 years, mean follow-up time of 3.9 years, and median follow-up of 7.2 years. A total of 1,950 M-HAQ measurements were analyzed. Baseline disease characteristics were recorded, and the association of these characteristics with the M-HAQ score was analyzed at baseline and longitudinally. Lower income and education levels, older age, and more severe skin involvement at enrollment were independent predictors of worse perceived functional disability over time (i.e., higher longitudinal M-HAQ levels). Higher longitudinal modified Rodnan skin scores correlated with higher M-HAQ scores, whereas higher longitudinal forced vital capacity percentage predicted values correlated with lower M-HAQ scores over time (P < 0.001 for both univariable and multivariable analyses). Moreover, higher baseline M-HAQ scores predicted higher mortality (hazard ratio 1.29, 95% confidence interval 1.09-1.52, P = 0.003). This large, longitudinal study of early disease SSc demonstrates that severity of skin disease and socioeconomic factors such as educational level and income are important predictors of perceived functional disability in SSc.

Identifiants

pubmed: 34738736
doi: 10.1002/acr.24812
pmc: PMC9068830
mid: NIHMS1751756
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1066-1070

Subventions

Organisme : NIAMS NIH HHS
ID : R61 AR078078
Pays : United States
Organisme : NIAMS NIH HHS
ID : P50 AR054144
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003167
Pays : United States
Organisme : NIAMS NIH HHS
ID : N01 AR002251-013
Pays : United States
Organisme : NIAMS NIH HHS
ID : K23 AR061436
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024148
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR055258
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR073284
Pays : United States

Informations de copyright

© 2021 The Authors. Arthritis Care & Research published by Wiley Periodicals LLC on behalf of American College of Rheumatology.

Références

Medicine (Baltimore). 2013 Jul;92(4):191-205
pubmed: 23793108
Arthritis Rheum. 2009 Oct 15;61(10):1403-11
pubmed: 19790132
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S4-13
pubmed: 22588760
Lancet. 2017 Oct 7;390(10103):1685-1699
pubmed: 28413064
Arthritis Rheumatol. 2018 Nov;70(11):1829-1834
pubmed: 29781588
J Rheumatol. 2007 Aug;34(8):1718-26
pubmed: 17611983
Medicine (Baltimore). 2002 Mar;81(2):139-53
pubmed: 11889413
Arthritis Rheum. 1991 Apr;34(4):403-13
pubmed: 1901491
Medicine (Baltimore). 2002 Mar;81(2):154-67
pubmed: 11889414
Arthritis Care Res. 1995 Sep;8(3):189-93
pubmed: 7654804
Am J Med Sci. 2016 Apr;351(4):366-73
pubmed: 27079342
Arthritis Res Ther. 2020 Oct 28;22(1):257
pubmed: 33115544
J Rheumatol. 2019 Dec;46(12):1597-1604
pubmed: 30709959
Arthritis Care Res. 1991 Mar;4(1):27-31
pubmed: 11188583
Rheumatol Int. 2017 Dec;37(12):2087-2094
pubmed: 29027012

Auteurs

Julia Chernis (J)

McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.

Maryam Buni (M)

The University of Texas MD Anderson Cancer Center, Houston.

Sarah Kazzaz (S)

The Methodist Hospital System, Houston, Texas.

Jun Ying (J)

Consultant, Houston, Texas.

Marka Lyons (M)

McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.

Shervin Assassi (S)

McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.

Maureen Mayes (M)

McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH